Macrogenics (MGNX) Shares Outstanding (Diluted Average) (2016 - 2026)

Macrogenics (MGNX) has 10 years of Shares Outstanding (Diluted Average) data on file, last reported at $63.4 million in Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $63.4 million, up 0.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $63.4 million (up 0.77% YoY), and the FY2025 annual result was $63.2 million, up 0.85% from the prior year.
• Shares Outstanding (Diluted Average) was little changed at $63.4 million in Q1 2026 per MGNX's latest filing, from $63.2 million in the prior quarter.
• Over five years, Shares Outstanding (Diluted Average) peaked at $63.4 million in Q1 2026 and troughed at $61.3 million in Q1 2022.
• A 5-year average of $62.3 million and a median of $62.3 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• On a YoY basis, Shares Outstanding (Diluted Average) climbed as much as 7.2% in 2022 and fell as far as 0.36% in 2022.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $61.4 million in 2022, then gained by 0.81% to $61.9 million in 2023, then advanced by 1.12% to $62.6 million in 2024, then increased by 0.85% to $63.2 million in 2025, then advanced by 0.47% to $63.4 million in 2026.
• Business Quant data shows MGNX's Shares Outstanding (Diluted Average) at $63.4 million in Q1 2026, $63.2 million in Q4 2025, and $63.1 million in Q3 2025.